4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-042890
SVP, General Counsel sold 50,000 shares at $136.46 ($6,823,000)
- SVP, General Counsel acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Howton David T · SVP, General Counsel
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-07-16 | Exercise or conversion : show line 1 in the form | +3,096 | $13.71 | $42,446 | 37,967 | D |
| 2018-07-16 | Sale : show line 2 in the form | −3,096 | $136.46 | $422,480 | 34,871 | D |
| 2018-07-16 | Exercise or conversion : show line 3 in the form | +9,056 | $13.71 | $124,158 | 43,927 | D |
| 2018-07-16 | Sale : show line 4 in the form | −9,056 | $136.46 | $1,235,782 | 34,871 | D |
| 2018-07-16 | Exercise or conversion : show line 5 in the form | +37,848 | $13.90 | $526,087 | 72,719 | D |
| 2018-07-16 | Sale : show line 6 in the form | −37,848 | $136.46 | $5,164,738 | 34,871 | D |
| Open-market sales · 50,000 sh · avg $136.46 · $6,823,000 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2018-07-16 | Exercise or conversion : show line 7 in the form Stock option (right to buy) | −3,096 | $13.71 | $42,446 | $13.71 | 2026-02-28 | 3,096 | 7,431 | D |
| 2018-07-16 | Exercise or conversion : show line 8 in the form Stock option (right to buy) | −9,056 | $13.71 | $124,158 | $13.71 | 2026-02-28 | 9,056 | 10,090 | D |
| 2018-07-16 | Exercise or conversion : show line 9 in the form Stock option (right to buy) | −37,848 | $13.90 | $526,087 | $13.90 | 2025-02-27 | 37,848 | 27,159 | D |
Loading xslF345X03/doc4.xml…